Global Rabies Vaccine for Pets Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rabies Vaccine for Pets Market Insights, Forecast to 2034
Rabies vaccine refers to the vaccine used to prevent rabies. There are many effective and safe vaccines available. The rabies vaccine can be given either before or some time after exposure to the virus (such as a dog or bat bite).
Global Rabies Vaccine for Pets market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Rabies Vaccine for Pets industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Rabies Vaccine for Pets key manufacturers include Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Bavarian Nordic, Dyntec, Sanofi-Pasteur and Tianjin Ringpu Bio-Technology, etc. Merck, Zoetis, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Rabies Vaccine for Pets were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Rabies Vaccine for Pets market and estimated to attract more attentions from industry insiders and investors.
Rabies Vaccine for Pets can be divided into Injectable Rabies Vaccine and Oral Rabies Vaccine, etc. Injectable Rabies Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Rabies Vaccine for Pets is widely used in various fields, such as Pet Hospital and Animal Epidemic Prevention Station, etc. Pet Hospital provides greatest supports to the Rabies Vaccine for Pets industry development. In 2022, global % sales of Rabies Vaccine for Pets went into Pet Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Rabies Vaccine for Pets market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rabies Vaccine for Pets market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Merck
Zoetis
Boehringer Ingelheim
Ceva
Virbac
Bavarian Nordic
Dyntec
Sanofi-Pasteur
Tianjin Ringpu Bio-Technology
Segment by Type
Injectable Rabies Vaccine
Oral Rabies Vaccine
Pet Hospital
Animal Epidemic Prevention Station
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rabies Vaccine for Pets plant distribution, commercial date of Rabies Vaccine for Pets, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rabies Vaccine for Pets introduction, etc. Rabies Vaccine for Pets Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Rabies Vaccine for Pets
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Rabies Vaccine for Pets market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Rabies Vaccine for Pets industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Rabies Vaccine for Pets key manufacturers include Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Bavarian Nordic, Dyntec, Sanofi-Pasteur and Tianjin Ringpu Bio-Technology, etc. Merck, Zoetis, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Rabies Vaccine for Pets were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Rabies Vaccine for Pets market and estimated to attract more attentions from industry insiders and investors.
Rabies Vaccine for Pets can be divided into Injectable Rabies Vaccine and Oral Rabies Vaccine, etc. Injectable Rabies Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Rabies Vaccine for Pets is widely used in various fields, such as Pet Hospital and Animal Epidemic Prevention Station, etc. Pet Hospital provides greatest supports to the Rabies Vaccine for Pets industry development. In 2022, global % sales of Rabies Vaccine for Pets went into Pet Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Rabies Vaccine for Pets market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rabies Vaccine for Pets market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
Virbac
Bavarian Nordic
Dyntec
Sanofi-Pasteur
Tianjin Ringpu Bio-Technology
Segment by Type
Injectable Rabies Vaccine
Oral Rabies Vaccine
Segment by Application
Pet Hospital
Animal Epidemic Prevention Station
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rabies Vaccine for Pets plant distribution, commercial date of Rabies Vaccine for Pets, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rabies Vaccine for Pets introduction, etc. Rabies Vaccine for Pets Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Rabies Vaccine for Pets
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports